Author:
Salehi Anahita,Namaei Parsa,TaghaviZanjani Fateme,Bagheri Sayna,Moradi Kamyar,Khodaei Ardakani Mohammad-Reza,Akhondzadeh Shahin
Funder
Tehran University of Medical Sciences and Health Services
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference67 articles.
1. Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial;Arabzadeh;Bipolar Disord.,2015
2. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial;Akhondzadeh;Prog. Neuropsychopharmacol. Biol. Psychiatry,2005
3. Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease;Beggiato;Front. Pharmacol.,2019
4. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents;Black;Psychopharmacology (Berl.),2011
5. Current perspectives in treating negative symptoms of schizophrenia: a narrative review (Review);Căpățînă;Exp Ther Med,2021
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献